Trial Phase: Syndemic Adapted Medly Uganda
ConditionMental Health
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University
About this trial
The purpose of this study is to evaluate the effectiveness of the Syndemic-Adapted Medly Uganda (SAMU) in improving mental health care among adults living with HIV and hypertension in Uganda. In sub-Saharan Africa (SSA), there is a high prevalence of depression and anxiety among people living with HIV (PLHIV) as well as alcohol use disorder (AUD). PLHIV who experience depression are less likely to link to HIV care, adhere to antiretroviral therapy, and achieve viral suppression. Building on research conducted to adapt Medly Uganda for mental health using a syndemic framework, this study aims to assess the effectiveness of SAMU on mental health screening and diagnosis. This will be accomplished through a two-arm trial in which 1. participants will be enrolled, screened, re-screened, and assessed for diagnosis and linkage to care for depression, anxiety and AUD and 2. evaluate the factors impacting sustained engagement in the SAMU program, through mixed methods.
Eligibility criteria
Qualifiers
Patient at a participating HIV clinic site
Currently living in Uganda with no intention of moving abroad in next 2 years
Access to a mobile phone
Basic reading skills in one or more of the offered languages (English, Luganda) as determined by the Research Assistant.
Disqualifiers
No access to a mobile phone
Inability to provide informed consent based on assessment by the onsite Research Assistant or HCW
Age >=18 years
Healthcare worker at participating site or caregiver for study participant at site
Trial design
Treatments tested in this trial
- Syndemic-Adapted Medly Uganda (SAMU)
Treatment groups
1,500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov